A dendritic cell therapy using autologous dendritic cells loaded with mRNA encoding a fusion of human LAMP and CMV pp65 protein to induce T cell immune response against glioblastoma cells.

An off-the-shelf plasmid DNA vaccine targeting CMV-associated antigens in newly diagnosed glioblastoma multiforme to elicit T cell and antibody responses.